Los Angeles Times

Chad Terhune

Writer

Chad Terhune previously covered the business of healthcare, including medical costs, patient safety and the rollout of the federal health law.  Prior to joining in 2012, he was an award-winning reporter for the Wall Street Journal and Businessweek. Chad spent more than a decade at the Journal and his stories on health insurance won a National Press Club award. At Businessweek, his stories on health reform and subprime mortgages earned recognition from the New York Press Club and Investigative Reporters and Editors. He graduated from the University of Florida. Terhune left The Times in January 2016.

Recent Articles

  • FDA retreats from recall of scope-cleaning machines

    FDA retreats from recall of scope-cleaning machines

    The Food and Drug Administration has dropped a recall of some 2,800 scope-cleaning machines in use at hospitals and clinics nationwide despite a finding by a top agency scientist last year that the action was "necessary to protect public health." The FDA had ordered the equipment off the market...

  • FDA retreats from recall of scope-cleaning machines

    FDA retreats from recall of scope-cleaning machines

    The Food and Drug Administration has dropped a recall of some 2,800 scope-cleaning machines in use at hospitals and clinics nationwide despite a finding by a top agency scientist last year that the action was “necessary to protect public health.” The FDA had ordered the equipment off the market...

  • Number of deadly infections from dirty scopes is far higher than previously estimated

    Number of deadly infections from dirty scopes is far higher than previously estimated

    The number of potentially deadly infections from contaminated medical scopes is far higher than what federal officials previously estimated, a new congressional investigation shows. As many as 350 patients at 41 medical facilities in the U.S. and worldwide were infected or exposed to tainted gastrointestinal...

  • Scope maker Olympus sought price hike amid superbug outbreak

    Scope maker Olympus sought price hike amid superbug outbreak

    Soon after doctors at UCLA's Ronald Reagan Medical Center traced deadly infections to tainted medical scopes last year, they pressed the device maker to lend them replacements. But Olympus Corp. refused. Instead, the Tokyo company offered to sell UCLA 35 new scopes for $1.2 million — a 28% increase...

  • California regulators are urged to scrutinize health insurance mega-mergers

    California regulators are urged to scrutinize health insurance mega-mergers

    California is becoming a battleground state in the fight over health insurance mega-mergers. Consumer advocates are putting pressure on regulators in California and a dozen other key states to scrutinize the deals amid concerns that consumers will be left with fewer choices and higher costs. There's...

  • Lawmaker asks SEC to investigate Olympus over failure to disclose outbreak report

    Lawmaker asks SEC to investigate Olympus over failure to disclose outbreak report

    A U.S. lawmaker is calling on the Securities and Exchange Commission to investigate Olympus Corp. in response to a Times article that detailed how the company kept selling its scopes despite warnings from a 2012 superbug outbreak in the Netherlands.In a letter sent Monday, Rep. Ted Lieu (D-Torrance)...

81°